Maharashtra, India

Pramod Kumar Jadhav




Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Pramod Kumar Jadhav: Innovator in Pharmaceutical Compounds

Introduction

Pramod Kumar Jadhav is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for the treatment of proliferative disorders such as cancer. With a total of two patents to his name, Jadhav's work is recognized for its potential impact on medical treatments.

Latest Patents

Jadhav's latest patents include "Enantiomerically pure compounds for the treatment of proliferative disorders" and "Enantioselective synthesis of pyrrolidines substituted with flavones, and intermediates thereof." The first patent focuses on an enantiomerically pure (+)-trans enantiomer of a compound that is useful for treating diseases mediated by the inhibition of cyclin-dependent kinases, such as cancer. The second patent details an enantioselective synthesis of pyrrolidines that are inhibitors of cyclin-dependent kinases, which can also be used for treating proliferative disorders.

Career Highlights

Throughout his career, Jadhav has worked with prominent companies such as Piramal Enterprises Limited and Piramal Life Sciences Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical research.

Collaborations

Jadhav has collaborated with notable coworkers, including Meenakshi Sivakumar and Manoj Shukla. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Pramod Kumar Jadhav is a distinguished inventor whose work in pharmaceutical compounds holds promise for the treatment of serious medical conditions. His contributions to the field are significant and reflect his dedication to innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…